HR+/HER2-breast cancer - Globe Thesis

Font Size: a A A

Keyword [HR+/HER2-breast cancer] Result: 1 - 9 \| Page: 1 of 1
1.	Experiment Study On The Effects Of Trastuzumab Combined With Fulvestrant In HR+/HER2+ Breast Cancer
2.	Analysis Of Influencing Factors And Efficacy Prediction Of Neoadjuvant Chemotherapy On HR Positive And HER2 Negative Breast Cancer
3.	The Ki-67 Cut-off Value In HR+/HER2-breast Cancer And The Different Expression Level With Early Recurrence And Metastasis
4.	HRI Confers Tamoxifen Resistance To HR+HER2-breast Cancer Cells By Activating EIF2A/OAS3/ERα Pathway
5.	Cancer/Testis Antigen MAGEC2 Promotes Resistance To CDK4/6 Inhibitors In HR+/HER2- Breast Cancer By Activating PI3K/AKT/mTOR Pathway
6.	Clinical Study On The Recurrence Risk Of HR+/HER2+ Breast Cancer And The Pathology And Prognosis Of Its Single-hormone Receptor Positive Subtypes
7.	Preliminary Research Of The Existence And Clinical Significance Of Basal Like Sub-cell Population In HR+/HER2-breast Cancer
8.	Long-term Outcomes By Neoadjuvant Efficacy Indexes In HR+ And HR+/HER2+ Breast Cancer:A Systematic Review And Meta-analysis
9.	Mechanism Research Of LGALS3BP In Regulating Sensitive To Adriamycin Therapy Of HR+/HER2-breast Cancer
<<First <Prev Next> Last>> Jump to